KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 83 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $10,128,000 | +4.6% | 135,076 | +5.1% | 0.01% | 0.0% |
| Q2 2015 | $9,679,000 | +63.4% | 128,529 | +8.8% | 0.01% | +100.0% |
| Q1 2015 | $5,924,000 | +72.0% | 118,144 | +18.9% | 0.00% | +50.0% |
| Q4 2014 | $3,444,000 | +21.0% | 99,329 | +14.3% | 0.00% | 0.0% |
| Q3 2014 | $2,846,000 | -13.6% | 86,893 | +1.2% | 0.00% | 0.0% |
| Q2 2014 | $3,294,000 | +20.9% | 85,864 | +25.3% | 0.00% | 0.0% |
| Q1 2014 | $2,725,000 | +15.5% | 68,545 | +8.2% | 0.00% | 0.0% |
| Q4 2013 | $2,359,000 | +27.7% | 63,343 | +56.6% | 0.00% | +100.0% |
| Q3 2013 | $1,848,000 | +178.3% | 40,442 | +64.7% | 0.00% | 0.0% |
| Q2 2013 | $664,000 | – | 24,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,382,722 | $69,344,000 | 3.43% |
| Versant Venture Management, LLC | 70,376 | $3,529,356,000 | 3.10% |
| AlpInvest Partners B.V. | 29,731 | $1,491,000 | 2.79% |
| Partner Investment Management, L.P. | 29,178 | $1,463,000 | 2.20% |
| PFM Health Sciences, LP | 1,242,509 | $62,312,000 | 1.72% |
| Aureus Asset Management, LLC | 130,307 | $6,535,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 444,999 | $22,317,000 | 1.49% |
| HealthCor Management, L.P. | 425,000 | $21,314,000 | 1.02% |
| Redmile Group, LLC | 225,062 | $11,287,000 | 1.01% |
| REGENTATLANTIC CAPITAL LLC | 174,454 | $8,749,000 | 0.77% |